At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Mild-moderate Plaque-type Psoriasis
In Brief
A Early Phase 1 clinical trial evaluating topical 1% methotrexate gel and clobetasol propionate 0.05% ointment for Pilot Study and Psoriasis. Completed, enrolled 2 participants across 1 site.
Detailed Summary
A pilot study on the formulation of topical methotrexate was conducted. Patients after baseline evaluation were randomly placed into either topical 1% methotrexate gel or clobetasol propionate 0.05% ointment which was applied for 6 weeks. PASI score was assessed at two-week intervals for a total of eight weeks. Blood chemistry parameters, whole abdomen ultrasound, and adverse drug reactions while on treatment and after eight weeks were monitored as secondary outcome measures.
Study Details
Timeline
Interventions
topical 1% methotrexate gel
clobetasol propionate 0.05% ointment